Varex Imaging Corp — Director's Dealing 2018

Jun 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Varex Imaging Corp (VREX)
CIK: 0001681622
Period of Report: 2018-06-05

Reporting Person: LaCasce Carl E. (SVP, Sales & Marketing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-05	Common Stock	M	11155	$19.21	Acquired	27971	Direct
2018-06-05	Common Stock	S	11155	$37.4182	Disposed	16816	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-05	Non-Qualified Stock Option (right to buy)	$19.21	M	11155	Disposed	2018-11-11	Common Stock (11155.0)	Direct

Footnotes

F1: Amount of securities beneficially owned at end of reporting period reflect 236 shares purchased on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

F2: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2018. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $37.86.

F3: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.